Vanda Pharmaceuticals
VNDA
#8442
Rank
NZ$0.54 B
Marketcap
NZ$8.96
Share price
0.39%
Change (1 day)
16.18%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2026 (TTM): -NZ$0.28 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.21 Billion. In 2025 the company made an earning of -NZ$0.27 Billion a decrease over its 2024 earnings that were of -NZ$71.04 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.28 Billion3.79%
2025 -NZ$0.27 Billion271.79%
2024 -NZ$71.04 Million191.43%
2023 -NZ$24.38 Million-320.45%
2022 NZ$11.05 M-84.99%
2021 NZ$73.66 M54.8%
2020 NZ$47.58 M19.42%
2019 NZ$39.84 M4.93%
2018 NZ$37.97 M-228.6%
2017 -NZ$29.53 Million-8.98%
2016 -NZ$32.45 Million-53.79%
2015 -NZ$70.21 Million-30.18%
2014 -NZ$0.11 Billion173.08%
2013 -NZ$36.82 Million-25.33%
2012 -NZ$49.31 Million163.61%
2011 -NZ$18.71 Million-221.15%
2010 NZ$15.43 M-124.53%
2009 -NZ$62.95 Million-29.44%
2008 -NZ$89.21 Million-36.2%
2007 -NZ$0.14 Billion21.81%
2006 -NZ$0.12 Billion170.55%
2005 -NZ$42.43 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$45.38 B-16,300.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$27.57 B-9,942.61%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$18.50 B-6,704.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$54.37 B-19,508.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$22.97 B-8,301.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$16.76 B-6,084.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-NZ$4.91 Million-98.25%๐Ÿ‡บ๐Ÿ‡ธ USA